These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


326 related items for PubMed ID: 15790420

  • 1. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis.
    ter Borg PC, Fekkes D, Vrolijk JM, van Buuren HR.
    BMC Gastroenterol; 2005 Mar 24; 5():11. PubMed ID: 15790420
    [Abstract] [Full Text] [Related]

  • 2. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634].
    ter Borg PC, van Os E, van den Broek WW, Hansen BE, van Buuren HR.
    BMC Gastroenterol; 2004 Jul 13; 4():13. PubMed ID: 15251034
    [Abstract] [Full Text] [Related]

  • 3. A pilot study exploring the role of glucocorticoid receptor variants in primary biliary cirrhosis and primary sclerosing cholangitis.
    ter Borg PC, Hagendorf A, van Buuren HR, Koper JW, Lamberts SW.
    Neth J Med; 2004 Oct 13; 62(9):326-31. PubMed ID: 15635817
    [Abstract] [Full Text] [Related]

  • 4. Cholestatic liver diseases and health-related quality of life.
    Younossi ZM, Kiwi ML, Boparai N, Price LL, Guyatt G.
    Am J Gastroenterol; 2000 Feb 13; 95(2):497-502. PubMed ID: 10685757
    [Abstract] [Full Text] [Related]

  • 5. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.
    Silveira MG, Mendes FD, Diehl NN, Enders FT, Lindor KD.
    Liver Int; 2009 Aug 13; 29(7):1094-100. PubMed ID: 19291181
    [Abstract] [Full Text] [Related]

  • 6. The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis.
    Boomkens SY, de Rave S, Pot RG, Egberink HF, Penning LC, Rothuizen J, Zondervan PE, Kusters JG.
    FEMS Immunol Med Microbiol; 2005 May 01; 44(2):221-5. PubMed ID: 15866219
    [Abstract] [Full Text] [Related]

  • 7. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence.
    Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D.
    Hepatology; 2006 Jul 01; 44(1):91-8. PubMed ID: 16800007
    [Abstract] [Full Text] [Related]

  • 8. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
    Bressler B, Pinto R, El-Ashry D, Heathcote EJ.
    Gut; 2005 Mar 01; 54(3):407-10. PubMed ID: 15710991
    [Abstract] [Full Text] [Related]

  • 9. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis.
    Ahboucha S, Pomier-Layrargues G, Vincent C, Hassoun Z, Tamaz R, Baker G, Butterworth RF.
    Neurochem Int; 2008 Mar 01; 52(4-5):569-74. PubMed ID: 17669554
    [Abstract] [Full Text] [Related]

  • 10. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
    Jones DE, Newton JL.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):471-6. PubMed ID: 17270003
    [Abstract] [Full Text] [Related]

  • 11. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis.
    Newton JL, Allen J, Kerr S, Jones DE.
    Liver Int; 2006 Mar 15; 26(2):197-202. PubMed ID: 16448458
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C.
    Ahboucha S, Butterworth RF, Pomier-Layrargues G, Vincent C, Hassoun Z, Baker GB.
    Neurogastroenterol Motil; 2008 Jun 15; 20(6):671-9. PubMed ID: 18282171
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
    Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD.
    Am J Gastroenterol; 2006 Sep 15; 101(9):2070-5. PubMed ID: 16879434
    [Abstract] [Full Text] [Related]

  • 16. Quality of life in patients with primary biliary cirrhosis.
    Poupon RE, Chrétien Y, Chazouillères O, Poupon R, Chwalow J.
    Hepatology; 2004 Aug 15; 40(2):489-94. PubMed ID: 15368455
    [Abstract] [Full Text] [Related]

  • 17. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
    Bedlow AJ, Donaldson PT, McFarlane BM, Lombard M, McFarlane IG, Williams R.
    J Clin Lab Immunol; 1989 Nov 15; 30(3):103-9. PubMed ID: 2642168
    [Abstract] [Full Text] [Related]

  • 18. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.
    Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J.
    Am J Gastroenterol; 2000 Mar 15; 95(3):760-7. PubMed ID: 10710071
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
    Maheshwari A, Yoo HY, Thuluvath PJ.
    Am J Gastroenterol; 2004 Mar 15; 99(3):538-42. PubMed ID: 15056099
    [Abstract] [Full Text] [Related]

  • 20. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure.
    Newton JL, Bhala N, Burt J, Jones DE.
    J Hepatol; 2006 Apr 15; 44(4):776-83. PubMed ID: 16487619
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.